Article Text

Download PDFPDF
Malignant pleural mesothelioma with heterologous elements
  1. Toshiaki Kawai1,
  2. Reishi Seki2,
  3. Kuniharu Miyajima3,
  4. Hiroshi Nakashima4,
  5. Takayuki Takeda5,
  6. Tomoyuki Murakami6,
  7. Keisuke Aoe7,
  8. Kazunori Okabe7,
  9. Keiichi Homma8,
  10. Yoshitane Tsukamoto9,
  11. Koichi Sunada10,
  12. Yasuhiro Terasaki11,
  13. Maki Iida12,
  14. Hideki Orikasa13,
  15. Kenzo Hiroshima14
  1. 1Toda Central Medical Laboratory, Toda, Japan
  2. 2Department of Diagnostic Pathology, Tokyo Saiseikai Central Hospital, Tokyo, Japan
  3. 3Department of Thoracic Surgery and Oncology, Niizashiki Central General Hospital, Niiza, Japan
  4. 4Department of Preventive Medicine and Public Health, National Defense Medical College, Tokorozawa, Japan
  5. 5Division of Respiratory Medicine, Uji-Tokushukai Medical Center, Uji, Japan
  6. 6Department of Pathology, Kanmon Medical Center, Shimonoseki, Japan
  7. 7Departments of Medical Oncology, and Thoracic Surgery, Yamaguchi Ube Medical Center, Ube, Japan
  8. 8Department of Pathology, Niigata Cancer Center Hospital, Niigata, Japan
  9. 9Department of Pathology, Takarazuka City Hospital, Takarazuka, Japan
  10. 10Division of Respiratory Medicine, Saiseikai Yokohamashi Tobu Hospital, Yokohama, Japan
  11. 11Department of Analytic Human Pathology, Nippon Medical School Hospital, Tokyo, Japan
  12. 12Department of Pathology, Yokosuka General Hospital Uwamachi, Yokosuka, Japan
  13. 13Department of Pathology, Kawasaki Municipal Hospital, Kawasaki, Japan
  14. 14Department of Pathology, Tokyo Women’s Medical University Yachiyo Medical Center, Yachiyo, Japan
  1. Correspondence to Dr Toshiaki Kawai, Toda Central Medical Laboratory, Toda, Saitama, Japan; t_kawai{at}tmg.or.jp

Abstract

Aims Malignant pleural mesothelioma with heterologous elements (such as osseous, cartilaginous or rhabdomyoblastic differentiation) is very rare. We tried to differentiate such mesothelioma cases from extraskeletal pleural osteosarcoma, which is very challenging.

Methods We compared 10 malignant pleural mesotheliomas (three biphasic and seven sarcomatoid types) with two pleural osteosarcomas using clinicopathological and immunohistochemical methods, and also fluorescence in situ hybridisation (FISH) to examine for homozygous deletion of p16.

Results The median age was 72 years for mesotheliomas, and 69 years for osteosarcoma. For mesothelioma, eight cases were male and two were female. Growth was diffuse in all mesothelioma cases except case 10, where it was localised, as it was for the two osteosarcomas. Among mesothelioma cases, 80% displayed osteosarcomatous and 60% chondromatous elements, while 10% exhibited rhabdomyoblastic ones. Immunohistochemical labelling for calretinin and AE1/AE3 was present in 8/10 and 7/10 mesotheliomas, respectively, but in only one osteosarcoma. Loss of methylthioadenosine phosphorylase was seen in 5/7 mesotheliomas. FISH analysis revealed homozygous deletion of p16 in 5/8 mesothelioma and 2/2 osteosarcoma. Median survival was 6.5 months after biopsy or surgical operation in mesothelioma, and 12 months after operation in osteosarcoma.

Conclusions Although median survival was longer for osteosarcoma than for malignant mesothelioma, we could not differentiate mesothelioma from pleural osteosarcoma on the combined basis of clinicopathological and immunohistochemical data, and FISH analysis. However, diffuse growth was more frequent in mesothelioma than in osteosarcoma.

  • pleura
  • immunohistochemistry
  • fish

Data availability statement

Data are available on reasonable request.

Statistics from Altmetric.com

Data availability statement

Data are available on reasonable request.

View Full Text

Footnotes

  • Handling editor Runjan Chetty.

  • Contributors They analysed their cases carefully, and contributed to our analysis.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.